Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
about
Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients.Treatment and prophylaxis of melioidosisSubstituted diphenyl ethers as a novel chemotherapeutic platform against Burkholderia pseudomallei.Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.Two-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei.Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response.Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.Membrane-Bound PenA β-Lactamase of Burkholderia pseudomalleiThe In Vitro Antibiotic Susceptibility of Malaysian Isolates of Burkholderia pseudomallei.Discovery of Inhibitors of Burkholderia pseudomallei Methionine Aminopeptidase with Antibacterial Activity.Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis PathogenMechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.Antibiotic resistance in Burkholderia speciesAntibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.Evaluating New Compounds to Treat Infections
P2860
Q33555304-962FE9E6-0870-4501-B6F7-A77D8521BE58Q34538191-5D61002F-0C44-4161-9FEE-D1B29C997B34Q35079030-D4F7E72D-8D63-4BB5-94CF-5056657C1421Q35616776-693C4EEA-F466-4E0F-99BE-29A34243E30DQ36224990-6A0421FE-F1BA-4C2E-9043-2AA78244BDDBQ36247396-E7767E23-EC87-454E-8705-1A2BA70ED30CQ36571985-C5A7FC0F-AE42-4A95-84C4-8F983926E41BQ36644825-B9397141-58D4-403C-A055-73F830BFEE6AQ37243076-03F36955-73F4-4C53-B69C-EDE773414B5FQ37410489-1D26F4D0-684D-4E0D-AE6B-E344359BF6AAQ37613045-87E78EBA-A373-482E-9627-1F99F328C199Q38066577-71BEF4C8-F876-4FE3-B7FA-DFDBA95F1893Q39295421-E760090A-1587-4CB7-8FF1-17645A9B01E0Q39383809-ACF667E3-B56F-4C46-AA3D-A06F60A1B81CQ39582866-516C72EC-1AB1-4741-942A-A3C14241A475Q40542863-B9564751-AFB4-4503-83FD-E53C6865AE57Q44423713-F2972BC8-6B92-4F90-AEC4-F94FD097EA1BQ50755283-55235FD1-CF6E-4DD9-A022-C94DB9EC70B6Q55715517-3FA05B88-FDE2-4FE5-A5A8-36C219F45928Q56375673-2E9A10FC-A393-4B63-8CAC-C4B83EF58748
P2860
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
@en
type
label
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
@en
prefLabel
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
@en
P2093
P2860
P50
P356
P1476
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
@en
P2093
James M Cook
Spenser R Wolken
P2860
P304
P356
10.2147/IDR.S35529
P407
P50
P577
2012-08-22T00:00:00Z